These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 4901383

  • 1. Similarities between neurologic effects of L-dopa and of apomorphine.
    Cotzias GC, Papavasiliou PS, Fehling C, Kaufman B, Mena I.
    N Engl J Med; 1970 Jan 01; 282(1):31-3. PubMed ID: 4901383
    [No Abstract] [Full Text] [Related]

  • 2. Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane.
    Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC.
    N Engl J Med; 1970 Jan 01; 282(1):5-10. PubMed ID: 5307796
    [No Abstract] [Full Text] [Related]

  • 3. Injected apomorphine and orally administered levodopa in Parkinsonism.
    Düby SE, Cotzias GC, Papavasiliou PS, Lawrence WH.
    Arch Neurol; 1972 Dec 01; 27(6):474-80. PubMed ID: 4563448
    [No Abstract] [Full Text] [Related]

  • 4. Levodopa in the treatment of Parkinsonism.
    Cotzias GC.
    JAMA; 1971 Dec 27; 218(13):1903-8. PubMed ID: 5171066
    [No Abstract] [Full Text] [Related]

  • 5. Metabolic modification of some neurologic disorders.
    Cotzias GC.
    JAMA; 1969 Nov 17; 210(7):1255-62. PubMed ID: 5394649
    [No Abstract] [Full Text] [Related]

  • 6. Parkinsonism and DOPA.
    Cotzias GC, Papavasiliou PS, Gellene R, Aronson RB.
    Trans Assoc Am Physicians; 1968 Nov 17; 81():171-83. PubMed ID: 4889342
    [No Abstract] [Full Text] [Related]

  • 7. [Apomorphine in the biochemical concept of Parkinson's tremor].
    Brinkmann R, Strian F.
    Nervenarzt; 1974 Sep 17; 45(9):474-6. PubMed ID: 4437688
    [No Abstract] [Full Text] [Related]

  • 8. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS, Cotzias GC, Düby SE, Steck AJ, Fehling C, Bell MA.
    N Engl J Med; 1972 Jan 06; 286(1):8-14. PubMed ID: 4550085
    [No Abstract] [Full Text] [Related]

  • 9. Observations on the range of efficacy of L-dopa.
    Klawans HL.
    Confin Neurol; 1971 Jan 06; 33(3):133-45. PubMed ID: 4940610
    [No Abstract] [Full Text] [Related]

  • 10. Effects of L-dopa on the H-reflex in parkinsonism.
    Fujita S, Cooper IS.
    J Am Geriatr Soc; 1971 Apr 06; 19(4):289-95. PubMed ID: 4936279
    [No Abstract] [Full Text] [Related]

  • 11. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
    Goodwin FK, Murphy DL, Brodie HK, Bunney WE.
    Biol Psychiatry; 1970 Oct 06; 2(4):341-66. PubMed ID: 4920729
    [No Abstract] [Full Text] [Related]

  • 12. Modification of Parkinsonism--chronic treatment with L-dopa.
    Cotzias GC, Papavasiliou PS, Gellene R.
    N Engl J Med; 1969 Feb 13; 280(7):337-45. PubMed ID: 4178641
    [No Abstract] [Full Text] [Related]

  • 13. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
    Donnelly EF, Chase TN.
    Dis Nerv Syst; 1973 Feb 13; 34(2):119-23. PubMed ID: 4706860
    [No Abstract] [Full Text] [Related]

  • 14. [L-DOPA therapy of parkinsonism].
    Refsum S.
    Nord Med; 1969 May 01; 81(18):570-1. PubMed ID: 5768311
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    Weintraub MI, Van Woert MH.
    N Engl J Med; 1971 Feb 25; 284(8):412-5. PubMed ID: 5540479
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.
    Muenter MD, Tyce GM.
    Mayo Clin Proc; 1971 Apr 25; 46(4):231-9. PubMed ID: 5573818
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.